Alexandra Glucksmann

Alexandra (Sandra) Glucksmann is a highly experienced professional in the biotechnology and pharmaceutical sectors, currently serving as Senior Advisor and Independent Board Member at Scenic Biotech, and as President & CEO of Sensorium Therapeutics. Other notable roles include Investment Committee Member at Adjuvant Capital, Scientific Advisor at Editas Therapeutics, Independent Board Member at REGENXBIO Inc., and former President and CEO of Cedilla Therapeutics. Additionally, Alexandra held the position of Entrepreneur In Residence at Third Rock Ventures and has a long-standing commitment to advancing women in science and technology through leadership roles at WEST. Alexandra's academic credentials include a PhD in Molecular Genetics and Cell Biology from the University of Chicago and a post-doctoral fellowship in Molecular Biology from the Massachusetts Institute of Technology.